Panacea Biotec joins hands with US-based Refana to develop COVID-19 vaccine

The company is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc to make a vaccine widely accessible around the world in an equitable manner through a joint venture company to be based in Ireland.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Ae6VC2
via IFTTT